This is the only input these recommendations use. It changes the case for creatine in particular, because ε4 carriers show measurably lower brain creatine stores. Leave it blank and you will see the general guidance.
Longevity supplements
The experimental frontier — emerging compounds with promising mechanisms but varying degrees of human evidence.
Longevity & Healthspan
FrontierThe compounds below represent the cutting edge of healthspan research. Mitopure (Urolithin A) has the strongest human data; NMNH and Apigenin are higher-upside but earlier-stage; creatine monohydrate has the longest safety track record but is included here for its emerging cognitive-longevity case (particularly for APOE ε4 carriers). Use these as a calculated bet on bleeding-edge biochemistry — not as established therapeutics.
Considered but not yet recommended
This guide has reviewed several other popular longevity compounds and decided the evidence is currently too early or too mixed to recommend them. They are not added to the stack above — but they are not dismissed either. If the human outcome data matures, they may be added in future versions of this guide. For transparency:
The threshold for inclusion in this guide is at least one well-designed human RCT showing meaningful biomarker or outcome change, plus a reasonable safety record. The compounds above either don't yet meet that bar (most), or have safety considerations that put them beyond the scope of a self-administered supplement guide (rapamycin in particular).
For UK supplement availability of the above, see the Longevity Box UK main product range — but please read the evidence summaries above before purchasing. Buying a supplement does not strengthen its evidence base.
Environmental load on longevity
The sixteen graded household and environmental exposures that used to sit here now have their own page, so they can grow as new topics are added.